https://ir.c3.ai/static-files/a4394b09-6a6d-40be-b0f2-4cfbbc89c176
April 5, 2023 There have been some questions regarding yesterday’s Kerrisdale report, to which we want to provide clarification.
Helocyte, a majority-owned subsidiary of Fortress Biotech, is developing Triplex for the prevention and treatment of cytomegalovirus in multiple transplant indications, as well as HIV Clinical trial funded by a
Two lawyers on former President Donald Trump’s legal team could be called upon as witnesses or get entangled in an obstruction investigation linked with the Mar-a-Lago search and seizure.
ADDvantage Technologies Group, Inc. (NASDAQ:AEY) ("ADDvantage Technologies" or the "Company") today announced that on December 1, 2023, it received a notification letter (the "Notification Letter") from the Listing